Ran Nussbaum's Net Worth

$331 Million

Estimate Recalculated Feb 23, 2024 05:15PM EST

Who is Ran Nussbaum?

Ran Nussbaum has an estimated net worth of $331 Million. This is based on reported shares across multiple companies, which include Kite Pharma, Inc., Keros Therapeutics, Inc., VBI Vaccines Inc/BC, Prevail Therapeutics Inc., UroGen Pharma Ltd., Eloxx Pharmaceuticals, Inc., Arno Therapeutics, Inc, and ARQULE INC.

SEC CIK

Ran Nussbaum's CIK is 0001609805

Past Insider Trading and Trends

2018 was Ran Nussbaum's most active year for acquiring shares with 22 total transactions. Ran Nussbaum's most active month to acquire stocks was the month of May. 2020 was Ran Nussbaum's most active year for disposing of shares, totalling 19 transactions. Ran Nussbaum's most active month to dispose stocks was the month of September. 2021 saw Ran Nussbaum paying a total of $8,021,353.75 for 5,968,489 shares, this is the most they've acquired in one year. In 2020 Ran Nussbaum cashed out on 12,379,920 shares for a total of $174,896,400.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arno Therapeutics, Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3/A
0
0
No matching records found

Kite Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-14.19K
0
Oct 3
Form 4
+123.59%
2.41K
4.36K
Jun 20
Form 4
9.83K
$69.11
$679,474.08
9.83K
May 9
Form 4
1.95K
1.95K
Jun 1
Form 4
0
0
Jun 9
Form 4
-100.00%
-305.43K
$55.35
-$16,906,458.74
0
Scheduled
Jun 1 - Jun 2
Form 4
-21.03%
-193.73K
$60.57
-$11,710,488.29
727.56K
Mar 27 - Mar 30
Form 4
2.2M
2.2M
Jun 25
Form 3
0
0
No matching records found

Keros Therapeutics, Inc. (KROS) Snapshot price: $52.27

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 6
Form 4
-0.15%
-7.18K
-$0.71
4.63M
Nov 29
Form 3/A
0
0
Form 4
0
0
Jun 1
Form 4
0
0
Jun 1
Form 4
+1.27%
60K
$50.00
$3,000,000.00
4.79M
Nov 17
Form 4
+31.88%
3.98M
$16.00
$6,999,984.00
16.48M
Apr 13
Form 3
0
0
No matching records found

VBI Vaccines Inc/BC (VBIV) Snapshot price: $0.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Prevail Therapeutics Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.58M
0
Jan 22
Form 4
0
0
Jun 17
Form 3
0
0
No matching records found